Media Releases

Perrigo's media releases will keep you updated on the latest news, product launches, foundation gifts and events across the organization.  

November 06, 2019

Perrigo Company plc Reports Third Quarter 2019 Financial Results

DUBLIN, Nov. 6, 2019 -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable Self-Care ProductsTM", today announced financial results for the third quarter ended September 28, 2019.

October 19, 2019

Perrigo Scientists Aim to Beat World Record While Inspiring Kids to Explore 'STEM' Careers

Perrigo scientists gave a ‘big’ science lesson to West Michigan families when they unveiled the world’s largest periodic table on Saturday. Officials from the Guinness Book of World Records were present to judge the feat.

October 09, 2019

Perrigo's “Quitting is Better” Campaign Named a Finalist for Corporate Social Responsibility Award

Perrigo Company plc (NYSE; TASE: PRGO) announced that its “Quitting is Better” nicotine replacement therapy campaign has earned national recognition from the Consumer Healthcare Products Association (CHPA) Educational Foundation for innovation and strategic marketing in the consumer healthcare products industry. 

October 08, 2019

Perrigo Voluntarily Halts Distribution of Ranitidine-Based Product

Upon receiving communication from the U.S. Food and Drug Administration (FDA) regarding the potential for presence of N-nitrosodimethylamine (NDMA) in certain ranitidine-based products, Perrigo Company plc promptly initiated testing of its externally sourced ranitidine API and ranitidine-based products.

September 16, 2019

Perrigo Charitable Foundation Donates More Than $20,000 to Hurricane Dorian Relief Efforts

The Perrigo Charitable Foundation and Perrigo employees have joined together to help victims of Hurricane Dorian both within the U.S. and internationally. Hurricane Dorian impacted multiple southeast states, the Caribbean, and the Bahamas as it made landfall last week.

September 05, 2019

Perrigo Advances Consumer Self-Care Growth Strategy with Acquisition of Prevacid®24HR

Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid® from GlaxoSmithKline.

July 15, 2019

Perrigo Donates $50,000 to the Saugatuck Center for the Arts to Support an Entire Year of Arts Education Programming

DUBLIN, Ireland and Allegan, Michigan – July 15, 2019 --The Perrigo Company Charitable Foundation is proud to announce a donation of $50,000 to the Saugatuck Center for the Arts (SCA) which will support an entire year of arts education programming throughout the tri-county areas of Allegan, Kent, and Ottawa Counties. 

July 08, 2019

Perrigo Completes Divestiture of Animal Health Business

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million.

July 03, 2019

Perrigo Announces FDA Final Approval and Launch of the AB-Rated Generic Version of Metrogel-Vaginal® Gel

Perrigo Company plc (NYSE; TASE: PRGO) today announced its product development partner received final approval from the U.S. Food and Drug Administration for its AB-rated Abbreviated New Drug Application (“ANDA”) referencing Metrogel-Vaginal® (metronidazole vaginal gel 0.75%).  Perrigo will acquire full ownership of the ANDA under a pre-existing arrangement with its partner within 30 days and anticipates launching this product immediately thereafter. 

July 02, 2019

Perrigo Completes Acquisition Of Ranir, Raises Guidance

Perrigo Company plc (NYSE; TASE: PRGO) today announced the successful completion of its acquisition of Ranir Global Holdings LLC ("Ranir"), the leading global store brand supplier of oral self-care products, for $750 million in cash. This transaction advances Perrigo's transformation to a consumer-focused, self-care company while enhancing its position as a global leader in consumer self-care solutions.

Press Inquiries

If you are a member of the press on deadline, please reach out to a member of our Global Investor Relations & Corporate Communications team.